Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,517,487 papers from all fields of science
Search
Sign In
Create Free Account
antineoplastons
Known as:
Antineoplaston Agent
, antineoplaston
A peptide, amino acid derivative, and/or organic acid extracted from blood serum, urine, or synthesized chemically, that inhibits the methylation of…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Preclinical studies of molecular-targeting diagnostic and therapeutic strategies against breast cancer
T. Fujii
,
G. Yokoyama
,
+6 authors
M. Kuwano
Breast Cancer
2008
Corpus ID: 34317312
We have investigated protein kinase C (PKC) signaling, a putative differentiation-related and metastasis suppressor gene Cap43…
Expand
2006
2006
Treatments for Astrocytic Tumors in Children
S. Burzynski
2006
Corpus ID: 70352368
Strategies for the treatment of childhood cancer have changed considerably during the last 50 years and have led to dramatic…
Expand
2005
2005
Antineoplaston induces G(1) arrest by PKCalpha and MAPK pathway in SKBR-3 breast cancer cells.
T. Fujii
,
A. Nakamura
,
+9 authors
H. Tsuda
Oncology Report
2005
Corpus ID: 44381939
Antineoplastons such as A10 include naturally occurring peptides and amino acid derivatives that control the neoplastic growth of…
Expand
2004
2004
Managing Social Conflict in Complementary and Alternative Medicine Research: The Case of Antineoplastons
Mitchell R. Hammer
,
W. Jonas
Integrative Cancer Therapies
2004
Corpus ID: 23059404
From December 1991 to December 1995, the National Cancer Institute (NCI) initiated phase II clinical trials of A10 and AS2-1…
Expand
1995
1995
Toxicological study on antineoplastons A-10 and AS2-1 in cancer patients.
H. Tsuda
,
H. Hara
,
+4 authors
Y. Sugita
The Kurume Medical Journal
1995
Corpus ID: 1110403
Antineoplastons, which were firstly described by Burzynski, are naturally occurring peptides and amino acid derivatives which…
Expand
1990
1990
Treatment of hormonally refractory cancer of the prostate with antineoplaston AS2-1.
S. Burzynski
,
E. Kubove
,
B. Burzynski
Drugs under experimental and clinical research
1990
Corpus ID: 21234336
Successful treatment of advanced cancer of the prostate which no longer responds to hormonal manipulation continues to be a…
Expand
1990
1990
Theoretical investigations on the structure and potential binding sites of antineoplaston A10 and experimental findings.
D. Michalska
Drugs under experimental and clinical research
1990
Corpus ID: 35685786
The essential biological importance of antineoplastons has motivated the present theoretical and experimental studies on the…
Expand
1987
1987
Phase I clinical studies of antineoplaston A5 injections.
S. Burzynski
,
E. Kubove
,
B. Burzynski
Drugs under experimental and clinical research
1987
Corpus ID: 39322779
Antineoplaston A5 is a mixture of small peptides and amino acid derivatives isolated from human urine which show a unique pattern…
Expand
1987
1987
Stereochemical modelling studies of the interaction of antineoplaston A10 with DNA.
L. Hendry
,
T. G. Muldoon
,
S. Burzynski
,
J. Copland
,
A. Lehner
Drugs under experimental and clinical research
1987
Corpus ID: 37506853
Antineoplaston A10 (3-phenylacetylamino-2,6-piperidinedione), a peptide analogue originally isolated from human urine, has been…
Expand
1977
1977
Antineoplaston A in cancer therapy. (I).
Burzynski
,
Z. Stolzmann
,
B. Szopa
,
E. Stolzmann
,
Kaltenberg Op
Physiological chemistry and physics
1977
Corpus ID: 23145865
Twenty-one patients with advanced cancer or leukemia were treated with antineoplaston A and followed for up to nine months…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required